Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000778598 | SCV000914906 | uncertain significance | Hepatic veno-occlusive disease-immunodeficiency syndrome | 2018-01-31 | criteria provided, single submitter | clinical testing | The SP110 c.342_346delCAGAG (p.Ser114ArgfsTer7) variant results in a frameshift, and is predicted to result in premature termination of the protein. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. Based on the variant frequency, disease prevalence, disease penetrance, and inheritance mode, this variant could not be ruled out of causing disease. Due to the potential impact of frameshift variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance, but suspicious for pathogenicity for hepatic veno-occlusive disease with immunodeficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |